Lysine Oxidation in Response to Arginine Supplementation
Determination of Lysine Oxidation in Response to Arginine Supplementation in Adult Men Using in Vivo Stable Isotope Techniques
Determination of Lysine Oxidation in Response to Arginine Supplementation in Adult Men Using in Vivo Stable Isotope Techniques
Sponsor study identifier
interventional
5
1 country
1
Study Start
July 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2017
Actual (reported)Study Completion
January 12, 2024
Actual (reported)This research study is investigating if consuming more of one amino acid (arginine) influences the digestion and absorption of another amino acid (lysine) due to competition in digestion, in a healthy adult population.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 12, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2015
Date type not reportedThis date has not been verified as actual or estimated.
July 14, 2015
Actual (reported)July 16, 2015
Actual (reported)December 2017
Actual (reported)January 12, 2024
Actual (reported)13CO2 production
Urine, plasma and breath samples will be collected during the study to measure the rate of oxidation of tracer with graded intake of arginine
8 hours (1 study day)
Graded arginine excess intake
Graded arginine excess intake will start at 50mg/kg/d on study day 1 followed by 100 mg/kg/d on study day 2 till the level reaches 300mg/kg/d on study day 6. Consisting of oral consumption of eight hourly experimental meals per study day - Includes 4 tracer free experimental meals containing a mixture of free amino acids, calories from a flavored liquid and protein free cookies and 4- labeled amino acid experimental meals.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
BC Children;s Hospital Research Institute, University of British Columbia
Vancouver, British Columbia, V5Z4H4, Canada
Rajavel Elango, PhD
University of British Columbia
5 participants (actual enrollment reported by the registry).
First Submitted
July 14, 2015
First Posted
July 16, 2015
Study Start
July 2015
Date type not reportedThis date has not been verified as actual or estimated.
L-Arginine in the Treatment of Peripheral Arterial Disease
Contact the study team to confirm eligibility.
Primary Completion
December 2017
Actual (reported)Study Completion
January 12, 2024
Actual (reported)Last Updated
July 25, 2024
Record last verified: 2024-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: